News

There is a lot of potential for RNAi therapeutics, and Cold Spring Harbor Laboratory (CSHL) researchers are working hard to paint a complete picture of the process, to improve therapies today and make better ones tomorrow.

Researchers have developed a way to attack synovial sarcoma, a rare tumor of soft tissues, using an investigational drug that triggers cell death.

Researchers have developed a new imaging system to quickly produce high-resolution 3D images in real-time, providing a quantitative analysis of organoids.

A new University of California, Irvine-led study identifies sex-specific circuits of muscle signaling to other tissues and that the organs and processes muscle impacts are markedly different between males and females.

A new study into how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2 is the first in history to compare how three different vaccine platforms trigger an immune response against the same pathogen.

Researchers have identified thousands of genes associated with lifespan and have found two key regulatory mechanisms that regulate their expression.

Progress is being made towards developing a blood test that uses the levels of phosphorylated Tau as a biomarker for Alzheimer's disease.

Researchers have revealed new details about how ketamine' mechanism of action on potassium channels in neurons, which could help to develop new treatments for depression.

Researchers have developed a cancer immunotherapy platform that is guided by ultrasound, generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.

Scientists have created a film that protects wounds as a bandage would. However it has several additional beneficial properties, it speeds up wound healing, repels bacteria, releases active pharmaceutical ingredients and dissolves by itself.